HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ASP2205

5-HT2C receptor agonist

Also Known As:

11-cyclopropyl-1-(2-methoxyethyl)-2,3,4,6,7,8,9,10-octahydro-1H-azepino(4,5-g)quinoline mono((2E)-but-2-enedioate)

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azepines: 11
    - ASP2205: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - ASP2205: 1

Experts

1.	Cernus, Dirk: 1 article (01/2019)
2.	Klarskov, Niels: 1 article (01/2019)
3.	Sawyer, Will: 1 article (01/2019)
4.	Van Till, Oliver: 1 article (01/2019)

Related Diseases

1.	Stress Urinary Incontinence 01/01/2019 - "ASP2205, a serotonin 5-HT2c receptor agonist, does not increase the urethral pressure and it is therefore unlikely that 5-HT 2c receptor agonists can be used as a treatment for stress urinary incontinence. "
2.	Nausea 01/01/2019 - "All subjects experienced predominantly central nervous system-related side effects (eg, dizziness and nausea) during ASP2205 treatment, which was most pronounced at 60 mg. "
3.	Dizziness (Lightheadedness) 01/01/2019 - "All subjects experienced predominantly central nervous system-related side effects (eg, dizziness and nausea) during ASP2205 treatment, which was most pronounced at 60 mg. "

Related Drugs and Biologics

1.	5-HT2C Serotonin Receptor
2.	Serotonin (5 Hydroxytryptamine)